Other Species / Isoforms
  FRK (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S37-p
ENPGALCsPQsQRHG
0 7
FRK (human) ENPGALCsPQsQRHG S37-p
FRK (mouse) ENPGAFCPPEAPRSQ P37
FRK (rat) ENPGAYCPPEANRSQ P37
S40-p
GALCsPQsQRHGHyF
0 4
FRK (human) GALCsPQsQRHGHyF S40-p
FRK (mouse) GAFCPPEAPRSQEPE A40
FRK (rat) GAYCPPEANRSQGQy A40
Y46-p
QsQRHGHyFVALFDy
Upstream
0 945
Treatment
  • HGF
FRK (human) QsQRHGHyFVALFDy Y46-p
FRK (mouse) PERSHGQyFVALFDY Y53-p
FRK (rat) ANRSQGQyFVALFDY Y47-p
Y53-p
yFVALFDyQARtAED
0 21
FRK (human) yFVALFDyQARtAED Y53-p
FRK (mouse) yFVALFDYQARTAED Y60
FRK (rat) yFVALFDYEARTAED Y54
T57-p
LFDyQARtAEDLsFR
0 1
FRK (human) LFDyQARtAEDLsFR T57-p
FRK (mouse) LFDYQARTAEDLsFR T64
FRK (rat) LFDYEARTAEDLSFH T58
S62-p
ARtAEDLsFRAGDKL
Upstream
0 6
Treatment
  • nocodazole
  • thymidine
FRK (human) ARtAEDLsFRAGDKL S62-p
FRK (mouse) ARTAEDLsFRAGDKL S69-p
FRK (rat) ARTAEDLSFHAGDKL S63
S92-p
LEKRRDGssQQLQGy
0 2
FRK (human) LEKRRDGssQQLQGy S92-p
FRK (mouse) LEKKGTGLGQQLQGY L99
FRK (rat) LEKKGPGLGQQLQGY L93
S93-p
EKRRDGssQQLQGyI
0 1
FRK (human) EKRRDGssQQLQGyI S93-p
FRK (mouse) EKKGTGLGQQLQGYI G100
FRK (rat) EKKGPGLGQQLQGYI G94
Y99-p
ssQQLQGyIPsNyVA
0 46
FRK (human) ssQQLQGyIPsNyVA Y99-p
FRK (mouse) LGQQLQGYIPSNYVA Y106
FRK (rat) LGQQLQGYIPSNYVA Y100
S102-p
QLQGyIPsNyVAEDR
0 3
FRK (human) QLQGyIPsNyVAEDR S102-p
FRK (mouse) QLQGYIPSNYVAEDR S109
FRK (rat) QLQGYIPSNYVAEDR S103
Y104-p
QGyIPsNyVAEDRSL
0 27
FRK (human) QGyIPsNyVAEDRSL Y104-p
FRK (mouse) QGYIPSNYVAEDRSL Y111
FRK (rat) QGYIPSNYVAEDRSL Y105
Y132-p
DAEKQLLysENKTGs
0 123
FRK (human) DAEKQLLysENKTGs Y132-p
FRK (mouse) DAEKQLLYSENQTGA Y139
FRK (rat) DAEKQLLYSENQTGA Y133
S133-p
AEKQLLysENKTGsF
0 10
FRK (human) AEKQLLysENKTGsF S133-p
FRK (mouse) AEKQLLYSENQTGAF S140
FRK (rat) AEKQLLYSENQTGAF S134
S139-p
ysENKTGsFLIRESE
0 1
FRK (human) ysENKTGsFLIRESE S139-p
FRK (mouse) YSENQTGAFLIRESE A146
FRK (rat) YSENQTGAFLIRESE A140
T178-p
DEGGFFLtRRRIFsT
0 3
FRK (human) DEGGFFLtRRRIFsT T178-p
FRK (mouse) DEGGFFLTRRKVFST T185
FRK (rat) DEGGFFLtRRKTFST T179-p
S184-p
LtRRRIFsTLNEFVS
0 1
FRK (human) LtRRRIFsTLNEFVS S184-p
FRK (mouse) LTRRKVFSTLNEFVN S191
FRK (rat) LtRRKTFSTLNEFVN S185
H192
TLNEFVSHyTKTSDG
0 2
FRK (human) TLNEFVSHyTKTSDG H192
FRK (mouse) TLNEFVNyYTTTSDG Y199-p
FRK (rat) TLNEFVNyYTTTSDG Y193-p
Y193-p
LNEFVSHyTKTSDGL
0 19
FRK (human) LNEFVSHyTKTSDGL Y193-p
FRK (mouse) LNEFVNyYTTTSDGL Y200
FRK (rat) LNEFVNyYTTTSDGL Y194
Y221-p
PAPFDLSyKTVDQWE
0 4
FRK (human) PAPFDLSyKTVDQWE Y221-p
FRK (mouse) PTPFDLSYKTADQWE Y228
FRK (rat) PTPFDLSYKTVDQWE Y222
S233-p
QWEIDRNsIQLLKRL
0 1
FRK (human) QWEIDRNsIQLLKRL S233-p
FRK (mouse) QWEIDRNSIQLLKRL S240
FRK (rat) QWEIDRNSIQLLKRL S234
Y303-p
CTLEDPIyIITELMR
0 1
FRK (human) CTLEDPIyIITELMR Y303-p
FRK (mouse) CTLEDPIYIITELMR Y310
FRK (rat) CTLEDPIYIITELMR Y304
Y317-p
RHGSLQEyLQNDTGS
0 2
FRK (human) RHGSLQEyLQNDTGS Y317-p
FRK (mouse) RHGSLQEYLQNDGGS Y324
FRK (rat) RHGSLQEYLQNDGGS Y318
Y368-p
LVGEHNIyKVADFGL
0 23
FRK (human) LVGEHNIyKVADFGL Y368-p
FRK (mouse) LVGEHNIYKVADFGL Y375
FRK (rat) LVGEHNIYKVADFGL Y369
K380
FGLARVFKVDNEDIy
0 1
FRK (human) FGLARVFKVDNEDIy K380
FRK (mouse) FGLARVFkVDNEDIy K387-ac
FRK (rat) FGLARVFKVDNEDIY K381
Y387-p
KVDNEDIyEsRHEIK
Upstream
1 69
Treatment
  • dasatinib
  • nocodazole
  • thymidine
FRK (human) KVDNEDIyEsRHEIK Y387-p
FRK (mouse) kVDNEDIyESKHEIK Y394-p
FRK (rat) KVDNEDIYESKHEIK Y388
S389-p
DNEDIyEsRHEIKLP
0 7
FRK (human) DNEDIyEsRHEIKLP S389-p
FRK (mouse) DNEDIyESKHEIKLP S396
FRK (rat) DNEDIYESKHEIKLP S390
S407-p
TAPEAIRsNkFSIKS
0 3
FRK (human) TAPEAIRsNkFSIKS S407-p
FRK (mouse) TAPEAIRTNKFSIKS T414
FRK (rat) TAPEAIRTNKFSIKS T408
K409-ac
PEAIRsNkFSIKSDV
0 1
FRK (human) PEAIRsNkFSIKSDV K409-ac
FRK (mouse) PEAIRTNKFSIKSDV K416
FRK (rat) PEAIRTNKFSIKSDV K410
Y490
LRWKLEDYFEtDssy
2 0
FRK (human) LRWKLEDYFEtDssy Y490
FRK (mouse) LHWKLEDyFETDCsy Y497-p
FRK (rat) LHWKLEDYFEPDSSy Y491
T493-p
KLEDYFEtDssysDA
0 1
FRK (human) KLEDYFEtDssysDA T493-p
FRK (mouse) KLEDyFETDCsySDT T500
FRK (rat) KLEDYFEPDSSySDT P494
S495-p
EDYFEtDssysDANN
0 2
FRK (human) EDYFEtDssysDANN S495-p
FRK (mouse) EDyFETDCsySDTNN C502
FRK (rat) EDYFEPDSSySDTNN S496
S496-p
DYFEtDssysDANNF
0 18
FRK (human) DYFEtDssysDANNF S496-p
FRK (mouse) DyFETDCsySDTNNF S503-p
FRK (rat) DYFEPDSSySDTNNF S497
Y497-p
YFEtDssysDANNFI
Upstream
2 512
Treatment
  • gefitinib
  • Su11274
FRK (human) YFEtDssysDANNFI Y497-p
FRK (mouse) yFETDCsySDTNNFI Y504-p
FRK (rat) YFEPDSSySDTNNFI Y498-p
S498-p
FEtDssysDANNFIR
0 6
FRK (human) FEtDssysDANNFIR S498-p
FRK (mouse) FETDCsySDTNNFIN S505
FRK (rat) FEPDSSySDTNNFIN S499